These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6430686)

  • 1. Discrepancy between immunoactivity and bioactivity of big-big and big human growth hormones in acromegaly.
    Tanaka T; Aiba T; Shishiba Y
    Endocrinol Jpn; 1984 Apr; 31(2):133-40. PubMed ID: 6430686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bioactivity and heterogeneity of human growth hormone in urine from acromegalic patients].
    Umezawa S; Yano H; Tanaka T; Hibi I; Teramoto A; Shishiba Y; Ishikawa E; Murakami Y
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):245-52. PubMed ID: 3042471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative differences between immunological and receptor binding activities of hGH in pituitary adenomas from patients with acromegaly.
    Hizuka N; Takano K; Shizume K; Asakawa K; Miyakawa M
    Endocrinol Jpn; 1984 Dec; 31(6):719-24. PubMed ID: 6099801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gel filtration studies of serum growth hormone in acromegaly following bromocriptine administration.
    Benker G; Sandmann K; Tharandt L; Hackenberg K; Reinwein D
    Horm Res; 1979; 11(3):151-60. PubMed ID: 488905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The heterogeneity of serum hPRL in a patient with a giant prolactinoma].
    Tanaka T; Aiba T; Shishiba Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1058-66. PubMed ID: 6519314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Big" growth hormone components from human plasma: decreased reactivity demonstrated by radioreceptor assay.
    Gorden P; Lesniak MA; Hendricks CM; Roth J
    Science; 1973 Nov; 182(4114):829-31. PubMed ID: 4746491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Big growth hormone forms in human plasma: immunochemical evidence for their pituitary origin.
    Stolar MW; Baumann G
    Metabolism; 1986 Jan; 35(1):75-7. PubMed ID: 3941610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers.
    Stolar MW; Amburn K; Baumann G
    J Clin Endocrinol Metab; 1984 Aug; 59(2):212-8. PubMed ID: 6376529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of human growth hormone and prolactin secreted in vitro: Immunoassay and radioreceptor assay correlations.
    Guyda JH
    J Clin Endocrinol Metab; 1975 Nov; 41(5):953-67. PubMed ID: 1184726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivity and immunoactivity of growth hormone during dynamic testing of patients with acromegaly.
    Baldwin AL; Aston R; Butler J; Buchanan C; Norman M
    Acta Endocrinol (Copenh); 1988 Nov; 119(3):326-32. PubMed ID: 3188807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of "big big prolactin" in serum and tumor extract in patients with PRL-secreting tumor.
    Ohnami S; Eto S; Ohnami S; Soejima T; Nakata H
    Endocrinol Jpn; 1987 Jun; 34(3):325-34. PubMed ID: 3115763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity of human growth hormone in urine from acromegalic patients.
    Tanaka T; Umezawa S; Yano H; Hibi I; Shishiba Y; Teramoto A; Ishikawa E; Murakami Y
    Horm Metab Res; 1989 Jun; 21(6):324-7. PubMed ID: 2673966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human growth hormone from acromegalic pituitary tumors.
    Chang WC; Shen AL; Chou CK; Ho LT
    Int J Pept Protein Res; 1984 Jun; 23(6):637-41. PubMed ID: 6469461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease in human growth hormone (HGH) levels during transsphenoidal surgery for acromegaly as a guide for prognosis.
    Yamada S; Shishiba Y; Kitano M; Seki Y; Umezu H; Umezu Y; Ohtsuki N; Yamazaki Y; Aiba T
    Endocrinol Jpn; 1985 Dec; 32(6):899-906. PubMed ID: 3833531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of monomeric human growth hormone and big growth hormone into different molecular weight forms in vitro and after injection into humans.
    Bieler EU; Pitout MJ; Stroud SW; van Rooyen RJ
    Horm Res; 1977; 8(1):29-36. PubMed ID: 892705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.
    Gorden P; Lesniak MA; Eastman R; Hendricks CM; Roth J
    J Clin Endocrinol Metab; 1976 Aug; 43(2):364-73. PubMed ID: 950368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of biological activity of prolactin molecular weight variants in human sera.
    Whitaker MD; Klee GG; Kao PC; Randall RV; Heser DW
    J Clin Endocrinol Metab; 1984 May; 58(5):826-30. PubMed ID: 6707188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cure of acromegaly by operative removal of an islet cell tumor of the pancreas.
    Caplan RH; Koob L; Abellera RM; Pagliara AS; Kovacs K; Randall RV
    Am J Med; 1978 May; 64(5):874-82. PubMed ID: 206142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man.
    Stolar MW; Baumann G; Vance ML; Thorner MO
    J Clin Endocrinol Metab; 1984 Aug; 59(2):235-9. PubMed ID: 6429181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.